INSERT THERAPEUTICS
Insert Therapeutics’ proprietary technologies provide for the intracellular delivery of a broad range of therapeutics. Insert Therapeutics has developed a new class of polymers that are designed and synthesized specifically for use as non-immunogenic, systemic delivery vehicles capable of accommodating therapeutics of any size, ranging from small molecules to plasmid DNA, as well as their combinations.
Similar Organizations
Coelacanth
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Rani Therapeutics
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
SanoGene Therapeutics
SanoGene Therapeutics is a biotechnology company that develops biopharmaceutical.
More informations about "Insert Therapeutics"
Insert Therapeutics - Wikipedia
Insert Therapeutics, Inc., now Calando Pharmaceuticals, Inc., is a medical research company that uses nanobiotechnology specializing in therapeutic agents that are conjugated, to facilitate …See details»
Firm | SBIR
Insert Therapeutics (Insert) is developing new non-viral systemic nucleic acid delivery systems that can be used to provide a constant in vivo source of IFNa. The Insert non-viral delivery …See details»
Insert Therapeutics - Crunchbase Company Profile
Insert Therapeutics’ proprietary technologies provide for the intracellular delivery of a broad range of therapeutics. Insert Therapeutics has developed a new …See details»
Insert Therapeutics Company Profile | Management and
Insert Therapeutics Profile and History Insert Therapeutics, Inc. (www.insertt.com) is using its proprietary, nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop …See details»
INSERT THERAPEUTICS, INC. – California Technology Ventures
Insert Therapeutics’ proprietary technologies provide for the intracellular delivery of a broad range of therapeutics. Insert Therapeutics has developed a new class of polymers that are designed …See details»
Insert Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Insert Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 14 literature, Disease Domain:Endocrinology and Metabolic Disease ...See details»
Calando Pharmaceuticals, Inc. (formerly Insert Therapeutics, Inc ...
- Provides intelligence on Calando Pharmaceuticals, Inc. (formerly Insert Therapeutics, Inc.) MandA, strategic partnerships and alliances, capital raising and private equity transactions. - …See details»
Insert Therapeutics Inc. - VentureRadar
Similar Companies: NantKwest USA n/a n/a. Integrated Nano-Technologies USA n/a INT’s Palladium™ device is a portable laboratory, allowing on-demand testing with >95% sensitivity …See details»
Insert Therapeutics, Inc. (Insert Therapeutics, Inc.) - 药物管线_专利_ …
了解Insert Therapeutics, Inc. (Insert Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的13篇文献，疾病领域:肿瘤，内分泌与代谢疾病，技术平台:小分子化药，药 …See details»
Insert Therapeutics - Products, Competitors, Financials, Employees ...
Insert Therapeutics' technologies provide for the intracellular delivery of a broad range of therapeutics. Insert Therapeutics has developed a new class of polymers that are designed …See details»
Calando Pharmaceuticals, Inc. and Insert Therapeutics Inc
Oct 31, 2007 Insert Therapeutics, Inc. (www.insertt.com) is using its proprietary, nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize …See details»
Insert Therapeutics - Wikiwand
Insert Therapeutics, Inc., now Calando Pharmaceuticals, Inc., is a medical research company that uses nanobiotechnology specializing in therapeutic agents that are conjugated, to facilitate …See details»
Insert Therapeutics, Receives FDA Approval for IT-101 Phase I …
Apr 3, 2006 Insert holds an exclusive license to Cyclosert and has conducted numerous animal studies showing the safety of the Cyclosert delivery platform and the efficacy of IT-101. "FDA …See details»
Insert Therapeutics - Tech Stack, Apps, Patents & Trademarks
Insert Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen Section. This year, …See details»
Insert Therapeutics to Initiate a Multinational Phase II Clinical Trial ...
Apr 18, 2008 Insert Therapeutics, Inc. has that it has filed with the U.S. Food and Drug Administration to initiate a Phase II clinical trial evaluating the safety and efficacy of its drug …See details»
Award - SBIR
Insert Therapeutics (Insert) is developing new non-viral systemic nucleic acid delivery systems that can be used to provide a constant in vivo source of IFNa. The Insert non-viral delivery …See details»
Insert Therapeutics - Crunchbase
Insert Therapeutics features a proprietary technologies provide for the intracellular delivery of a broad range of therapeutics.See details»
Preclinical Results of the Camptothecin-Polymer Conjugate IT-101 …
Nov 16, 2007 Disclosure: Employment: Thomas Schluep and Julienne Duringer are employed by Insert Therapeutics, Inc. Consultancy: Stephen J. Forman and Mark E. Davis are …See details»
Promising New Nanomedical Cancer Therapy Also Highlights Tech …
Aug 13, 2007 The company that made the clinical trials possible is Insert Therapeutics, which Davis founded with the help of Larry Gilbert of Caltech's tech transfer office. Insert …See details»
About – Apinovo Pharma Innovations
A founder, director or advisor to numerous technology companies, including Cyrano Sciences, Coelacanth, Pharmacopeia, Insert Therapeutics, Calhoun Vision and Symyx Technologies; …See details»